Tumor progression is a hallmark in GB because recurrent GBs are driven by intrinsic (e.g., MGMT upregulation and increased tumor mutation burden) and extrinsic (e.g., hypoxia and immuno-suppressive tumor microenvironments) mechanisms developing resistance to therapies [16]. Here, MGMT is linked to neoplasm.